慢性稳定性心绞痛演变与结局的国际观察性分析:跨国CLARIFY研究
基线22.1%患者有心绞痛,1年内39.6%未经血运重建自行消失;持续或新发心绞痛与5年心血管死亡或心梗风险升高独立相关,而保守治疗下1年内缓解者风险与无心绞痛者相似。
要点
- 稳定性冠心病患者中约22.1%基线有心绞痛,多数1年内未经血运重建可缓解。
- 持续或新发心绞痛与5年心血管死亡/心梗风险升高独立相关。
- 保守治疗下1年内心绞痛缓解者预后与从未有心绞痛者相似。
核心结论
- 心绞痛影响近四分之一稳定性冠心病患者,但多数患者未经事件或冠脉血运重建即可缓解。
- 保守治疗下1年内心绞痛缓解预测结局与无心绞痛者相似,而持续或新发心绞痛与更差结局相关。
- 鉴于多数心绞痛患者症状可能缓解且常规血运重建未显示结局获益,本研究强调稳定性冠心病保守管理的价值。
研究设计与样本
- 逐年映射无心血运重建或新发心肌梗死患者的心绞痛状态,并探索心绞痛缓解前一年内医疗干预的使用。
- 采用多变量分析评估1年心绞痛状态变化对5年结局的影响。
主要发现
- 7212例(22.1%)患者基线报告心绞痛,其中39.6%在1年时未经冠脉血运重建心绞痛消失,随后逐年进一步下降。
- 基线无心绞痛患者中,每年2.0%至4.8%新发心绞痛。
- 5年随访期间,7773例患者心绞痛得到控制,其中心绞痛缓解通过增加抗心绞痛治疗获11.1%、通过冠脉血运重建获4.5%、未改变药物或血运重建获84.4%。
- 与基线和1年均无心绞痛患者相比,持续心绞痛(校正风险比1.32,95%CI 1.12-1.55)和保守管理下1年新发心绞痛(校正风险比1.37,95%CI 1.11-1.70)均独立与5年心血管死亡或心肌梗死风险升高相关。
- 保守管理下1年心绞痛已缓解者心血管死亡或心肌梗死风险不高于从未有心绞痛者(校正风险比0.97,95%CI 0.82-1.15)。
临床怎么用
- 对稳定性冠心病心绞痛患者,可优先考虑保守管理,多数患者症状可自行缓解。
- 持续或新发心绞痛提示5年心血管死亡或心梗风险升高,需加强监测与二级预防。
- 保守管理下1年内缓解的心绞痛患者预后与无心绞痛者相似,支持避免常规血运重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although angina is common in patients with stable coronary artery disease, limited data are available on its prevalence, natural evolution, and outcomes in the era of effective cardiovascular drugs and widespread use of coronary revascularization. METHODS: Using data from 32 691 patients with stable coronary artery disease from the prospective observational CLARIFY registry (Prospective Observational Longitudinal Registry of Patients with Stable Coronary Artery Disease), anginal status was mapped each year in patients without new coronary revascularization or new myocardial infarction. The use of medical interventions in the year preceding angina resolution was explored. The effect of 1-year changes in angina status on 5-year outcomes was analyzed using multivariable analysis. RESULTS: Among 7212 (22.1%) patients who reported angina at baseline, angina disappeared (without coronary revascularization) in 39.6% at 1 year, with further annual decreases. In patients without angina at baseline, 2.0% to 4.8% developed angina each year. During 5-year follow-up, angina was controlled in 7773 patients, in whom resolution of angina was obtained with increased use of antianginal treatment in 11.1%, with coronary revascularization in 4.5%, and without any changes in medication or revascularization in 84.4%. Compared to patients without angina at baseline and 1 year, persistence of angina and occurrence of angina at 1 year with conservative management were each independently associated with higher rates of cardiovascular death or myocardial infarction (adjusted hazard ratio, 1.32 [95% CI, 1.12-1.55] for persistence of angina; adjusted hazard ratio, 1.37 [95% CI, 1.11-1.70] for occurrence of angina) at 5 years. Patients whose angina had resolved at 1 year with conservative management were not at higher risk of cardiovascular death or myocardial infarction than those who never experienced angina (adjusted hazard ratio, 0.97 [95% CI, 0.82-1.15]). CONCLUSIONS: Angina affects almost one-quarter of patients with stable coronary artery disease but resolves without events or coronary revascularization in most patients. Resolution of angina within 1 year with conservative management predicted outcomes similar to lack of angina, whereas persistence or occurrence was associated with worse outcomes. Because most patients with angina are likely to experience resolution of symptoms, and because there is no demonstrated outcome benefit to routine revascularization, this study emphasizes the value of conservative management of stable coronary artery disease. Registration: URL: https://www.isrctn.com; Unique identifier: ISRCTN43070564.
引用
- Mesnier J, Ducrocq G, Danchin N, et al. International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study. Circulation. 2021. PMID: 34261331. doi:10.1161/CIRCULATIONAHA.121.054567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。